Dear reader,
There are rare occasions when a gold mine goes into production - but it’s still invisible to investors and Wall Street.
That exact scenario is playing out with one small miner that recently poured its first ounces of gold from a brand new mine.
The market is blind to this company - for now. But that all changes when revenues become obvious in earnings reports.
That means we only have weeks to get into this firm…
You need to own this company now - before the company’s production is made public.
Click here to get the full briefing before it’s too late.
Best,
Garrett Goggin, CFA, CMT
Lead Analyst and Founder, Golden Portfolio
The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)
Authored by Chris Markoch. First Published: 1/18/2026.
What You Need to Know
- Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. That often means targeting companies with disruptive technologies, participation in an emerging trend, or a compelling turnaround story. Many of these companies will never survive or scale, but if even one delivers, investors can see impressive returns.
For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks. The ranking is based on the number of MarketBeat subscribers following each company. While that's no guarantee of success, it can provide additional conviction in a stock’s potential.
Trump's new AI budget just passed — one stock could soar (Ad)
In a quiet move few people noticed...
President Trump just green-lit what could become the biggest AI budget in history.
Some investors consider any stock trading at $5 or less a penny stock. However, the stocks in this screener follow the traditional definition: shares priced below $1. These stocks are highly volatile. Be sure to conduct your own research and understand your risk tolerance before initiating a position.
Vaxart: A Potential Game-Changer for Global Immunization Efforts
Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases, including influenza, norovirus and COVID-19. Unlike traditional injectable vaccines, Vaxart’s tablet-based platform aims to simplify distribution and improve global accessibility.
The bull case for Vaxart centers on its innovative approach. If the company can obtain FDA approval and successfully scale, its oral vaccines could reduce logistical barriers to mass immunization campaigns and unlock significant licensing partnerships. Positive trial results or a commercial collaboration could dramatically shift sentiment and valuation given the stock’s current low share price.
Clinical risk is the biggest challenge. Vaxart has yet to bring a product to market, and vaccine development is costly and unpredictable. Competition from well‑capitalized incumbents also limits visibility. For now, Vaxart is more of a long-term speculative bet on platform validation than on near-term profitability.
The MarketBeat analyst ratings show only a single analyst covering Vaxart, which is not uncommon but may give some investors pause. VXRT also has only 18% institutional ownership. On the positive side, the stock carries about 2% short interest, which could temper some volatility.
Microvision: Developing Cost-Effective LiDAR Units for Autonomous Driving
Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure and industrial sensing. The company’s hardware and software solutions enable precise 3D mapping needed for self-driving and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions.
The bull case for Microvision rests on two main factors: the ongoing push toward vehicle automation and the potential for partnerships with major automotive manufacturers. If Microvision can demonstrate superior performance or cost advantages, it could win supply agreements or licensing deals that materially improve revenue visibility. Its technology may also find applications beyond vehicles, including robotics and smart-city projects, adding optionality to the growth story.
Despite the promise, Microvision faces stiff competition from LiDAR players such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ) and Ouster (NYSE: OUST). The path to profitability remains uncertain, and recurring delays in commercial adoption of LiDAR technology have frustrated investors.
MVIS is covered by three analysts and has a consensus price target of $2.50, implying roughly 169% upside from its Jan. 15 closing price. Like many speculative names, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%). Long-term investors should be prepared for significant volatility.
Datavault AI: Trying to Democratize Data Ownership
Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization and digital-asset management. The company helps organizations turn raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain and analytics tools, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems may overlook.
The bullish thesis for Datavault AI lies in its niche focus and scalability potential. As data becomes an increasingly valuable commodity, businesses and individuals are exploring ways to safely monetize digital information. Datavault’s technology could benefit from growing AI adoption and increased emphasis on data sovereignty. Early-stage traction or strategic partnerships could act as catalysts for investor confidence.
That said, Datavault AI operates in a highly experimental space. The company’s business model is evolving, and its path to meaningful revenue remains unproven. Institutions own less than 1% of the stock, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
This message is a paid sponsorship from Golden Portfolio, a third-party advertiser of Earnings360 and MarketBeat.
If you have questions or concerns about your account, please contact MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Place, Sixth Floor, Sioux Falls, South Dakota 57103-7078. United States of America..
